Where is the live CopyMark page for USPTO serial 75912653?

The live record is at https://getcopymark.com/trademark/75912653. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns CANCER TALK?

According to the public USPTO record for serial number 75912653, the listed owner(s) include: VITAL OPTIONS.

What is USPTO serial number 75912653?

Serial number 75912653 is the USPTO application identifier for the mark CANCER TALK. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover CANCER TALK?

The public record lists International Classes: 016, 041. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: CANCER TALK Serial# 75912653 | status 603; last event EXPT | Trademark Info & Attorney Guidance

Q: What is the current status of CANCER TALK?

CANCER TALK (75912653) currently shows USPTO status code 603 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CANCER TALK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

VITAL OPTIONS
Sherman Oaks, CA
Other trademarks owned by VITAL OPTIONS

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey L. Van Hoosear

JEFFREY L VAN HOOSEAR KNOBBE, MARTENS, OLSON & BEAR LLP2040 MAIN ST 14TH FLIRVINE, CA 92614UNITED STATES

Goods and services

Class	Description	Status	First use
016	books and newsletters, all featuring information regarding cancer survivors, families of cancer patients, cancer support groups, and the physical, emotional, legal, and social aspects of cancer and beyond cancer	ACTIVE	—
041	educational and entertainment services in the nature of on-going radio shows offered by airlines featuring information about cancer survivors, families or cancer survivors and cancer victims, and the physical, emotional, legal, and social aspects of cancer and beyond cancer	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Jan 21, 2003	EXPT	EXPARTE APPEAL TERMINATED	—
Dec 3, 2002	ABN3	ABANDONMENT - AFTER EX PARTE APPEAL	—
Sep 30, 2002	RECD	ACTION DENYING REQ FOR RECON MAILED	—
Sep 30, 2002	IUAA	USE AMENDMENT ACCEPTED	—
Aug 6, 2002	TCCA	TEAS CHANGE OF CORRESPONDENCE RECEIVED	—
Jul 17, 2002	AUPC	AMENDMENT TO USE PROCESSING COMPLETE	—
Mar 20, 2002	JURT	JURISDICTION RESTORED TO EXAMINING ATTORNEY	—
Mar 20, 2002	EXPI	EX PARTE APPEAL-INSTITUTED	—
Mar 4, 2002	IUAF	USE AMENDMENT FILED	—
Jan 28, 2002	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Dec 26, 2001	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jun 18, 2001	CNFR	FINAL REFUSAL MAILED	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 5, 2001	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Aug 1, 2000	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 7, 2000	DOCK	ASSIGNED TO EXAMINER	—
Jun 30, 2000	DOCK	ASSIGNED TO EXAMINER	—

CANCER TALK